TruBridge Appoints Merideth Wilson as GM of Financial Health TruBridge, Inc. (NASDAQ: TBRG), a leading provider of healthcare solutions, has announced the appointment of Merideth Wilson as the new Financial…
Verastem Unveils Critical FDA Review of Avutometinib-Defactinib for Ovarian Cancer Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company dedicated to advancing new cancer treatments, has announced that the U.S. Food and…
Takeda Announces HYQVIA® 10% Injection Approval in Japan for Agammaglobulinemia Takeda (TSE:4502/NYSE:TAK) has announced that the Japanese Ministry of Health, Labour and Welfare has approved HYQVIA® [Immune Globulin Infusion 10%…
Allurion Technologies Announces Reverse Stock Split Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, has announced that its Board of Directors has approved a one-for-twenty-five reverse stock…
Clinical Trials: Ellipse Launches Program in the Middle East Ellipses Pharma Limited, a global drug development company focused on advancing cancer treatments, has launched its first large-scale Phase 1/2 oncology…
Henry Schein, Inc. (Nasdaq: HSIC), along with Team Schein Members (TSMs) from around the globe, is once again brightening the holiday season through its 26th annual “Holiday Cheer” program. This…
Aptorum Group Limited (NASDAQ: APM), a clinical-stage biopharmaceutical company focused on addressing unmet medical needs in oncology, autoimmune, and infectious diseases, today released its business update and financial results for…
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily, next-generation CFTR (cystic fibrosis transmembrane conductance regulator) modulator. ALYFTREK…
ZIVO Bioscience, Inc. (OTCQB: ZIVO), a leading biotech and agtech R&D company focused on developing therapeutic, medicinal, and nutritional products derived from proprietary algal cultures, has announced positive preliminary results…
Peter Hinchliffe, CEO of MedLumics, stated, “This marks a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system, utilizing Pulsed Field Ablation (PFA) and Optical Coherence Reflectometry (OCR)…
FlexIt, a leader in virtual fitness and wellness, is excited to announce the launch of FlexTogether™, a groundbreaking platform designed to connect individuals globally through innovative wellness experiences. This new…
Vivani Medical, Inc. (Nasdaq: VANI), an innovative biopharmaceutical company specializing in novel, ultra long-acting drug implants, today announced the initiation of screening and enrollment for its first-in-human clinical trial, LIBERATE-1™,…